Loryn Longbrake

Recommended Articles

• Michael J. Fox's Impact on Parkinson’s Disease

  Michael J. FoxMichael J. Fox, born as Michael Andrew Fox in 1961, is a Canadian-born actor, who received his breakthrough in Family Ties, an American sitcom. He consecutively received three Emmy awards as lead actor in this comedy series. He was the lead character in the adventure comedy film, Back...

• Am I at Risk for Developing Breast Cancer?

  Breast cancer is identified to be a major killer of middle-aged women, and the second most common cause of death by cancer. It is estimated that one out of every eight  American women living up to 95-years-old develop breast cancer. The number of deaths from breast carcinoma is now declining due to...

• What Causes Mumps?

  Mumps is a viral infection caused by a certain virus belonging to the paramyxoviruses family. This condition is common in children, teens, and young adults. The virus might also get into your cerebrospinal fluid, which surrounds and shields your brain and spine. Once it has entered,the virus can...

• What is Cystic Fibrosis?

  Cystic fibrosis is a life-threatening, inherited disorder, which affects the secretory glands producing mucus and sweat. Fluids secreted by the glands are usually thin. In this disease, the secretions become thick and sticky and block all passageways and ducts, particularly of the lungs and...

• New Research May Find a Breakthrough in Celiac Disease

  The organization, Beyond Celiac, states that about one in 100 Americans have celiac disease and their quality of life is negatively affected. There is hope on the horizon; however, a partnership between an industrial pharmaceutical company and a university lab has potentially found a promising...

• NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma

  The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...